1969
DOI: 10.1111/j.1699-0463.1969.tb04520.x
|View full text |Cite
|
Sign up to set email alerts
|

Heterotransplantation of a Human Malignant Tumour to “Nude” Mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
142
0
6

Year Published

1979
1979
2015
2015

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 627 publications
(148 citation statements)
references
References 3 publications
0
142
0
6
Order By: Relevance
“…Nude mice preserve the morphology and genetics of primary tumors and are thus commonly used to study tumor MDR (Rygaard, Povlsen, 1969;Shen et al, 2005;Li et al, 2005). In this study, combined treatment with cDDP and GSTsi significantly restored the sensitivity of transplanted tumor cells to cDDP, suggesting that recombinant lentivirus targeting the GST-π gene can successfully reverse the chemoresistance of esophageal cancer cells.…”
Section: Discussionmentioning
confidence: 99%
“…Nude mice preserve the morphology and genetics of primary tumors and are thus commonly used to study tumor MDR (Rygaard, Povlsen, 1969;Shen et al, 2005;Li et al, 2005). In this study, combined treatment with cDDP and GSTsi significantly restored the sensitivity of transplanted tumor cells to cDDP, suggesting that recombinant lentivirus targeting the GST-π gene can successfully reverse the chemoresistance of esophageal cancer cells.…”
Section: Discussionmentioning
confidence: 99%
“…Until today, using human cells or primary tumor tissues to produce xenograft models have become the main method of current in-vivo tumor research (Rygaard & Povlsen, 1969).…”
Section: Development Of Anti-tumor Modelsmentioning
confidence: 99%
“…It is important to implant the xenograft into the immunocompromised mice and commonly the T-cell deficient ''nude'' mice or NOD-SCID (non-obese diabetic/severe combined immunodeficiency) mice are used (Rygaard & Povlsen, 1969). The xenograft models of CRC are commonly used to assess newer therapeutics and understand the pathogenesis of human disease.…”
Section: Xenograft Models Of Colon Cancermentioning
confidence: 99%